A practical synthesis of optically active (R)-2-propyloctanoic acid: Therapeutic agent for Alzheimer's disease

Bulletin of the Chemical Society of Japan

Volumn 73, Issue 2, 2000, Pages 423-428

  Hasegawa, Tomoyuki ^a   Yamamoto, Hisashi ^a  

^a NAGOYA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARUNDIC ACID; HYDROGEN PEROXIDE; OCTANOIC ACID DERIVATIVE; TETRABUTYLAMMONIUM; UNCLASSIFIED DRUG;

ARTICLE; DRUG SYNTHESIS; REACTION ANALYSIS;

EID: 0034100244     PISSN: 00092673     EISSN: None     Source Type: Journal    
DOI: 10.1246/bcsj.73.423     Document Type: Article

References (32)

1. a) F. J. Liozzi and R. J. Lasek, Science, 237, 642 (1987).
2. b) Y. Uchida and M. Tomonaga, Brain Res., 481, 191 (1989).
3. c) R. A. Moumdijian, J. P. Antel, and V. W. Yong, Brain Res., 547, 223 (1991).
4. N. Tateishi, H. Ohno, K. Kishimoto, and S. Ohuchida, Japan Patent 7-316092 (1995).
5. a) C. Lambert, K. Uchimoto, and H. Nozaki, Tetrahedron Lett., 25, 5323 (1984).
6. b) K. Kishimoto and H. Nakai, Japan Patent 7-98328 (1995).
7. a) D. A. Evans and J. M. Takacs, Tetrahedron Lett., 21, 4233 (1980).
8. b) P. E. Sonnet and R. R. Heath, J. Org. Chem., 45, 3137 (1980).
9. K. Kishimoto and H. Nakai, Japan Patent 7-102693 (1995).
10. a) J. D. Morrison, "Asymmetric Synthesis," Academic Press, New York (1984), Vol. 3, p. 2.
11. b) G. R. Stephenson, "Advanced Asymmetric Synthesis," Chapman & Hall, (1996), p. 46.
12. a) D. A. Evans, L. R. Mcgee, M. D. Ennis, and D. J. Mathre, J. Am. Chem. Soc., 103, 2876 (1981).
13. b) D. A. Evans, M. D. Ennis, and D. J. Mathre, J. Am. Chem. Soc., 104, 1737 (1982).
14. c) D. A. Evans, Aldrichimica Acta, 15, 318 (1982).
15. d) D. A. Evans, M. T. Bilodeau, T. C. Somers, J. Clardy, D. Cherry, and Y. Kato, J. Org. Chem., 56, 5750 (1991).
16. e) K. J. Hale, V. M. Delisser, and S. Manaviazar, Tetrahedron Lett., 49, 7613 (1992).
17. a) T. Miyake, M. Seki, Y. Nakamura, and H. Ohmizu, Tetrahedron Lett., 37, 3129 (1996).
18. b) K. Kondo, M. Seki, T. Kuroda, and T. Yamanaka, J. Org. Chem., 62, 2877 (1997).
19. a) A. G. Myers, B. H. Yang, and J. L. Gleason, J. Am. Chem. Soc., 116, 9361 (1994).
20. b) A. G. Myers and L. Mckinstry, J. Org. Chem., 61, 2428 (1996).
21. c) A. G. Myers, J. L. Gleason, T. Yoon, and D. W. Kung, J. Am. Chem. Soc., 119, 656 (1997).
22. a) W. Oppolzer, R. Moretti, and S. Thomi, Tetrahedron Lett., 30, 5603 (1989).
23. b) W. Oppolzer, S. Rosset, and J. De. Brabander, Tetrahedron Lett., 38, 1539 (1997).
24. a) A. S. Cavallo and A. Adib, Tetrahedron, 48, 2453 (1992).
25. b) See for the same N-acylation condition of oxazolidinone auxiliaries: D. J. Ager, D. R. Allen, and D. R. Schaad, Synthesis, 1996, 1283.
26. w=0.036, GOF=2.540.
27. a) T. Hasegawa and H. Yamamoto, Synlett, 1998, 882.
28. b) See for another recent approach: O. Miyata, Y. Fujiwara, A. Nishiguchi, H. Honda, T. Shinada, I. Ninomiya, and T. Naito, Synlett, 1994, 637.
29. T. Hasegawa and H. Yamamoto, Synlett, 1999, 84.
30. S. Matsumura, H. Imafuku, Y. Takahashi, and K. Toshima, Chem. Lett., 1993, 251.
31. W. M. Pearlman, Tetrahedron Lett., 17, 1663 (1967).
32. K. Kurata, S. Tanaka, and K. Takahashi, Chem. Pharm. Bull., 24, 538 (1976).